{
    "Title": "Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World",
    "URL": "https://doi.org/10.1371/journal.pntd.0009354",
    "Published": "April 20, 2021",
    "Subject_Areas": [
        "Benzimidazoles",
        "Onchocerciasis",
        "Drug administration",
        "Adverse reactions",
        "Loa loa",
        "Drug safety",
        "Neurological drug therapy",
        "Strongyloidiasis"
    ],
    "Authors": {
        "Jérémy T. Campillo": [
            "TransVIHMI, Université Montpellier, Institut de Recherche pour le Développement (IRD), INSERM, Montpellier, France",
            "Department of medical pharmacology and toxicology, CHU Montpellier, Montpellier, France"
        ],
        "Michel Boussinesq": [
            "TransVIHMI, Université Montpellier, Institut de Recherche pour le Développement (IRD), INSERM, Montpellier, France"
        ],
        "Sébastien Bertout": [
            "TransVIHMI, Université Montpellier, Institut de Recherche pour le Développement (IRD), INSERM, Montpellier, France",
            "Laboratoire de Parasitologie et Mycologie Médicale, Université de Montpellier, Montpellier, France"
        ],
        "Jean-Luc Faillie": [
            "Department of medical pharmacology and toxicology, CHU Montpellier, Montpellier, France",
            "EA 2415, IDESP, University of Montpellier, Montpellier, France"
        ],
        "Cédric B. Chesnais": [
            "TransVIHMI, Université Montpellier, Institut de Recherche pour le Développement (IRD), INSERM, Montpellier, France"
        ]
    }
}